XML 33 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net income $ 64,890,000 $ 97,176,000 $ 81,111,000
Adjustments to reconcile net income to cash flows provided by operating activities:      
Depreciation and amortization 39,153,000 35,630,000 37,952,000
Non-cash stock-based compensation expense 15,978,000 11,990,000 16,131,000
Non-cash closure and impairment charges 9,240,000 3,594,000 2,927,000
Non-cash interest expense 3,290,000 3,505,000 3,226,000
Deferred income taxes (6,520,000) (13,822,000) (1,071,000)
Deferred revenue (6,278,000) (4,224,000) (4,474,000)
Loss (gain) on extinguishment of debt 0 10,000 (210,000)
(Gain) loss on disposition of assets (3,150,000) 2,359,000 (2,536,000)
Other (4,204,000) (3,552,000) (5,160,000)
Changes in operating assets and liabilities:      
Accounts receivable, net (671,000) 1,913,000 (2,574,000)
Deferred rent receivable 8,522,000 9,003,000 7,928,000
Income tax receivables and payables 667,000 1,160,000 8,326,000
Operating lease assets and liabilities (12,530,000) 7,256,000 (11,823,000)
Gift card receivables and payables (678,000) 5,095,000 2,783,000
Other current assets 7,618,000 1,911,000 (12,706,000)
Accounts payable 1,032,000 (16,027,000) (3,665,000)
Accrued employee compensation and benefits (6,368,000) (1,748,000) (16,264,000)
Accrued advertising expenses (1,441,000) (14,711,000) (10,020,000)
Other current liabilities (390,000) 4,622,000 (545,000)
Cash flows provided by operating activities 108,160,000 131,140,000 89,336,000
Cash flows from investing activities      
Principal receipts from notes, equipment contracts and other long-term receivables 12,264,000 9,319,000 17,057,000
Additions to property and equipment (14,069,000) (37,172,000) (35,318,000)
Proceeds from sale of property and equipment 3,021,000 10,000 17,028,000
Additions to long-term receivables (718,000) (1,069,000) (1,069,000)
Acquisition of business, net of cash acquired (8,452,000) (101,000) (78,264,000)
Other (497,000) (1,084,000) (338,000)
Cash flows used in investing activities (8,451,000) (30,097,000) (80,904,000)
Cash flows from financing activities      
Proceeds from issuance of long-term debt, including revolving line of credit 0 530,000,000 100,000,000
Repayment of long-term debt 0 (651,713,000) (38,768,000)
Repayments of revolving credit facility 0 (30,000,000) 0
Payment of debt issuance costs 0 (8,044,000) (6,289,000)
Dividends paid on common stock (31,302,000) (31,715,000) (30,765,000)
Repurchase of common stock (12,066,000) (26,130,000) (120,452,000)
Principal payments of finance lease and financing obligations (5,638,000) (6,431,000) (8,946,000)
Proceeds from stock options exercised 0 3,812,000 241,000
Repurchase of restricted stock for tax payments upon vesting (2,667,000) (4,355,000) (2,867,000)
Tax payments for share settlement of restricted stock units (30,000) (859,000) (955,000)
Cash flows used in financing activities (51,703,000) (225,435,000) (108,801,000)
Net change in cash, cash equivalents and restricted cash 48,006,000 (124,392,000) (100,369,000)
Cash, cash equivalents and restricted cash at beginning of year 200,592,000 324,984,000 425,353,000
Cash, cash equivalents and restricted cash at end of year 248,598,000 200,592,000 324,984,000
Supplemental disclosures      
Interest paid 79,231,000 73,976,000 64,599,000
Income taxes paid 38,332,000 28,409,000 28,085,000
Non-cash conversion of accounts receivable to notes receivable 3,254,000 1,367,000 84,000
Non-cash balance sheet gross-up of receivables and other accrued expenses $ 11,000,000 $ (11,000,000) $ 0